Price
No data yet.
Social Signal Score
Revenue
$0.00Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Marc de Garidel
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 80
- Beta
- -0.23
- Country
- FR
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- 28.19
Financials
Revenue
$0.00-100.0%Net Income
$-287.69MEBITDA
$-256.06MFree Cash Flow
$-71.28MEPS (diluted)
$-2.10Shares Outstanding (diluted)
69.53M+649.9%Operating Expenses
$72.09MCash & Debt
$530.16MReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-336.10M | $-4.65 |
| 2024 | $0.00 | $-176.24M | $-2.80 |
| 2023 | $0.00 | $-147.74M | $-3.43 |
| 2022 | $0.00 | $-60.74M | $-3.18 |
| 2021 | $0.00 | $-42.45M | $-2.75 |
| 2020 | $63.0K | $-37.55M | $-2.62 |
| 2019 | $2.0K | $-30.63M | $-2.51 |
| 2018 | $18.0K | $-15.82M | $-1.56 |
| 2017 | $10.0K | $-11.22M | $-1.14 |
| 2016 | $127.0K | $-14.31M | $-1.48 |
| 2015 | $42.0K | $-15.95M | $-1.65 |
| 2014 | $14.0K | $-5.08M | $-0.73 |
| 2013 | $73.9K | $-5.89M | $-0.64 |
Valuation
ABVXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
115Social Signal Score
Mentions (1)
- Newszacks.com·6h ago·Positive
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why Abivax SA Sponsored ADR (ABVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
View source ↗
Earnings
Mon, Sep 21(in 12 days)
Consensus estimate $-0.96 per share
Typical surprise +0.3% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, May 22$-0.71 vs $-1.07beat
- Mon, Mar 23$-1.19 vs $-1.70beat
- Mon, Dec 15$-2.47 vs $-0.79miss
- Mon, Sep 8$-0.86 vs $-0.90beat
- Mon, Jun 2$-0.97 vs $-0.76miss
- Mon, Mar 24$-1.68 vs $-1.59miss
Estimates and results for ABVX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.